In vivo and in vitro effects of tumour specific antibodies with chlorambucil.
D000042:Absorption; D000818:Animals; D000912:Antibodies, Neoplasm / Q000008:administration & dosage*; D000961:Antilymphocyte Serum; D001665:Binding Sites; D002699:Chlorambucil / Q000008:administration & dosage*; D046508:Culture Techniques; D003601:Cytotoxicity Tests, Immunologic; D004357:Drug Synergism; D006041:Goats / Q000276:immunology; D007106:Immune Sera / Q000302:isolation & purification; D007074:Immunoglobulin G; D008223:Lymphoma / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011817:Rabbits / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D000912:Antibodies, Neoplasm; D000961:Antilymphocyte Serum; D007106:Immune Sera; D007074:Immunoglobulin G; D002699:Chlorambucil